Rode Secours

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz et al. · The Lancet HIV · 2019 · 38 citations · Full text

Public Health, Health Sciences, Pharmacotherapy +12

Cost-Effectiveness of Early Versus Standard Antiretroviral Therapy in HIV-Infected Adults in Haiti

Serena P. Koenig, Heejung Bang, Patrice Sévère et al. · PLoS Medicine · 2011 · 33 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group

Caroline H. Shiboski, Huichao Chen, Rode Secours et al. · PLoS ONE · 2015 · 24 citations · Full text

Dentistry, Oral Medicine, Community Oral Health +12

CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001

S. E. Collins, Marc Antoine Jean Juste, Serena P. Koenig et al. · The International Journal of Tuberculosis and Lung Disease · 2014 · 21 citations

Public Health, Immunology, Infectious Diseases +15

Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial

Ashita S. Batavia, Rode Secours, P Gómez Espinosa et al. · PLoS ONE · 2016 · 19 citations · Full text

Dentistry, Oral Medicine, Oral Pathology +17